Amyloid β neurotoxicity is IDO1–Kyn–AhR dependent and blocked by IDO1 inhibitor
Open Access
- 12 June 2020
- journal article
- letter
- Published by Springer Science and Business Media LLC in Signal Transduction and Targeted Therapy
- Vol. 5 (1), 1-3
- https://doi.org/10.1038/s41392-020-0188-9
Abstract
No abstract availableFunding Information
- Science and Technology Commission of Shanghai Municipality (NO. 2018SHZDZX01)
This publication has 5 references indexed in Scilit:
- IDO and Kynurenine Metabolites in Peripheral and CNS DisordersFrontiers in Immunology, 2020
- Plasma neurofilament light chain and amyloid-β are associated with the kynurenine pathway metabolites in preclinical Alzheimer's diseaseJournal of Neuroinflammation, 2019
- Effects of the Novel IDO Inhibitor DWG-1036 on the Behavior of Male and Female 3xTg-AD MiceFrontiers in Pharmacology, 2019
- Intersection of AHR and Wnt Signaling in Development, Health, and DiseaseInternational Journal of Molecular Sciences, 2014
- Induction of Dickkopf-1, a Negative Modulator of the Wnt Pathway, Is Associated with Neuronal Degeneration in Alzheimer's BrainJournal of Neuroscience, 2004